Momentum Stock Watch: MEDNAX, Inc. (MD)

Company Profile:

MEDNAX, Inc. is a national health solutions partner comprised of the nation’s leading providers of physician services. It provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services. As of December 31, 2017, the company’s network consisted of approximately 4,075 affiliated physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

Recent News:

For the 2018 third quarter, the company expects earnings per share will be in a range of $0.72 to $0.77 per diluted share and Adjusted EPS will be in a range of $0.94 to $0.99

The company reported earnings of $0.85 per diluted share for the three months ended June 30, 2018. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $1.07.

On Aug. 02, 2018, the company announced that its Board of Directors has authorized the repurchase of up to $500 million of the Company’s common stock.


Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.


Profitability – Measures the historical price movement of the stock.


Solvency – Measures the solvency of the company based on several ratios.


Efficiency – Measures the strength and historic growth of a company’s return on invested capital.



MD’s strengths can be seen in its better growth, better profitability, strong solvency and robust efficiency compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in MACD and Stochastic oscillator, the RSI stands at 72.45 with positive bias. We rate MEDNAX, Inc. (MD) a STRONG BUY.

About the Author

has written 11405 stories on this site.

Copyright © 2012 Nine Stocks